常州市存仁生物工程有限公司

产品 > Integrase/CCR5 > HIV integrase > Dolutegravir(GSK1349572)度鲁特韦
产品名称 : Dolutegravir(GSK1349572)度鲁特韦
型号 : CR1159
CAS : 1051375-16-6
 放大                   返回
←[上一个产品]             


产品详细:

Description of:Dolutegravir(GSK1349572)
Dolutegravir (DTG, GSK1349572) is an integrase inhibitor being developed for the treatment of human immunodeficiency virus (HIV)-1 infection by GlaxoSmithKline (GSK) on behalf of Shionogi-ViiV Healthcare LLC. DTG is metabolized primarily by uridine diphosphate glucuronyltransferase (UGT)1A1, with a minor role of cytochrome P450 (CYP)3A, and with renal elimination of unchanged drug being extremely low (< 1% of the dose).


Theoretical analysis:Dolutegravir(GSK1349572)
MF:C20H19F2N3O5
MW:419.4
Purity:98%
Solubility:unknow
CAS No: 1051375-16-6

Availability and price:Dolutegravir(GSK1349572)
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :
orders@chemrenblock.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days

 若要询价或订购,请打销售电话咨询:0519-85788828,或加QQ:2500035664咨询,量大从优,我们会尽快回复。
注意事项:本产品是化学试剂,仅供实验室使用


相关产品 :
Elvitegravir
Elvitegravir
MK-2048
MK-2048